Oregon State University researchers have developed a new weapon in the battle against antibiotic-resistant germs – a molecule that neutralizes the bugs’ ability to destroy the antibiotic.
Scientists at OSU were part of an international collaboration that demonstrated the molecule’s ability to inhibit expression of an enzyme that makes bacteria resistant to a wide range of penicillins.
The molecule is a PPMO, short for peptide-conjugated phosphorodiamidate morpholino oligomer. The enzyme it combats is known as New Delhi metallo-beta-lactamase, or NDM-1, and it’s accompanied by additional genes that encode resistance to most if not all antibiotics.
“We’re targeting a resistance mechanism that’s shared by a whole bunch of pathogens,” said Bruce Geller, professor of microbiology in OSU’s College of Science and College of Agricultural Sciences, who’s been researching molecular medicine for more than a decade. “It’s the same gene in different types of bacteria, so you only have to have one PPMO that’s effective for all of them, which is different than other PPMOs that are genus specific.”
The Oregon State study showed that in vitro the new PPMO restored the ability of an antibiotic — in this case meropenem, an ultra-broad-spectrum drug of the carbapenem class — to fight three different genera of bacteria that express NDM-1. The research also demonstrated that a combination of the PPMO and meropenem was effective in treating mice infected with a pathogenic strain of E. coli that is NDM-1 positive.
Results of the study, supported by a grant from the National Institutes of Health, were recently published in the Journal of Antimicrobial Chemotherapy.
Geller says the PPMO will likely be ready for testing in humans in about three years.
“We’ve lost the ability to use many of our mainstream antibiotics,” Geller said. “Everything’s resistant to them now. That’s left us to try to develop new drugs to stay one step ahead of the bacteria, but the more we look the more we don’t find anything new. So that’s left us with making modifications to existing antibiotics, but as soon as you make a chemical change, the bugs mutate and now they’re resistant to the new, chemically modified antibiotic.”
That progression, Geller explains, made the carbapenems, the most advanced penicillin-type antibiotic, the last line of defense against bacterial infection.
“The significance of NDM-1 is that it is destroys carbapenems, so doctors have had to pull out an antibiotic, colistin, that hadn’t been used in decades because it’s toxic to the kidneys,” Geller said. “That is literally the last antibiotic that can be used on an NDM-1-expressing organism, and we now have bacteria that are completely resistant to all known antibiotics. But a PPMO can restore susceptibility to antibiotics that have already been approved, so we can get a PPMO approved and then go back and use these antibiotics that had become useless.”
Receive an email update when we add a new ANTIBIOTIC RESISTANCE article.
The Latest on: Antibiotic resistance
via Google News
The Latest on: Antibiotic resistance
- Baby's Meningitis Case Highlights Growing Danger of Antibiotic Resistanceon August 7, 2020 at 1:36 pm
(HealthDay News) -- Antibiotic-resistant bacteria affected the treatment of meningitis at a major children's hospital in Washington, D.C. This single case at Children's National Hospital raises ...
- New gonorrhea test identifies patients who will respond to oral antibioticon August 7, 2020 at 10:09 am
A new test for gonorrhea can determine whether those infected will respond successfully to the inexpensive oral antibiotic ciprofloxacin, according to a study published Friday by Clinical Infectious ...
- UK-India experts seek to stop antibiotic waste that creates more superbugson August 7, 2020 at 6:38 am
Waste generated by India's drug manufacturing industry could be damaging environmental bacteria and creating 'superbugs' that are resistant to antibiotics—prompting a UK-India scientific intervention.
- Efflux pump activity potentiates the evolution of antibiotic resistance across S. aureus isolateson August 7, 2020 at 2:15 am
Some bacterial lineages appear to be pre-disposed to evolving antibiotic resistance. Here, the authors show that differential expression of an efflux pump causes widespread variation in evolvability ...
- Team develops peptide that makes drug-resistant bacteria sensitive to antibiotics againon August 6, 2020 at 9:07 am
Scientists at Nanyang Technological University, Singapore (NTU Singapore) have developed a synthetic peptide that can make multidrug-resistant bacteria sensitive to antibiotics again when used ...
- NTU develops peptide that makes drug-resistant bacteria sensitive to antibiotics againon August 6, 2020 at 6:53 am
Scientists at NTU Singapore have developed a synthetic peptide that can make multidrug-resistant bacteria sensitive to antibiotics again when used together with traditional antibiotics, offering hope ...
- Racing the clock to stop drug-resistant superbugson August 5, 2020 at 10:40 am
If something isn't done now, antibiotic-resistant bacteria could kill as many as 10 million people a year by 2050. A little-known Boston nonprofit could be our best hope.
- Worldwide Oral Antibiotics Industry to 2027 - Featuring Mylan, Pfizer & Sanofi Among Others - ResearchAndMarkets.comon August 5, 2020 at 7:40 am
The "Oral Antibiotics Market, by Class, Application, Drug Origin, Spectrum of Activity and Drug Type: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ...
- Rapid diagnostic for gonorrhea wins $19 million federal prize competition to combat antibiotic resistanceon August 5, 2020 at 7:29 am
A diagnostic test capable of accurately and reliably detecting the microorganism that causes gonorrhea and rapidly determining in under 30 minutes if the microorganism is susceptible to a single-dose ...
via Bing News